ATE278681T1 - Dibenzofluorene derivative als antitumormittel - Google Patents
Dibenzofluorene derivative als antitumormittelInfo
- Publication number
- ATE278681T1 ATE278681T1 AT99965865T AT99965865T ATE278681T1 AT E278681 T1 ATE278681 T1 AT E278681T1 AT 99965865 T AT99965865 T AT 99965865T AT 99965865 T AT99965865 T AT 99965865T AT E278681 T1 ATE278681 T1 AT E278681T1
- Authority
- AT
- Austria
- Prior art keywords
- formula
- carbon atoms
- group
- substituted
- tumor agent
- Prior art date
Links
- XNKVIGSNRYAOQZ-UHFFFAOYSA-N dibenzofluorene Chemical class C12=CC=CC=C2C2=CC=CC=C2C2=C1CC1=CC=CC=C12 XNKVIGSNRYAOQZ-UHFFFAOYSA-N 0.000 title abstract 2
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000003368 amide group Chemical group 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/203,650 US6184224B1 (en) | 1998-12-01 | 1998-12-01 | Antitumor dibenzofluorene derivatives |
| PCT/US1999/027691 WO2000032583A1 (en) | 1998-12-01 | 1999-11-22 | Antitumor dibenzofluorene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE278681T1 true ATE278681T1 (de) | 2004-10-15 |
Family
ID=22754784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99965865T ATE278681T1 (de) | 1998-12-01 | 1999-11-22 | Dibenzofluorene derivative als antitumormittel |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US6184224B1 (de) |
| EP (1) | EP1135379B1 (de) |
| JP (1) | JP2002531445A (de) |
| AT (1) | ATE278681T1 (de) |
| CA (1) | CA2352878A1 (de) |
| DE (1) | DE69920953T2 (de) |
| WO (1) | WO2000032583A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6849348B2 (en) * | 2002-12-31 | 2005-02-01 | Eastman Kodak Company | Complex fluorene-containing compounds |
| US20050107430A1 (en) * | 2003-10-29 | 2005-05-19 | Banik Bimal K. | Antimicrobial and antiviral compounds |
| JP5030534B2 (ja) * | 2006-11-01 | 2012-09-19 | 出光興産株式会社 | アミノジベンゾフルオレン誘導体及びそれを用いた有機エレクトロルミネッセンス素子 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA743137A (en) | 1966-09-20 | Bui-Quoc-Huong | Preparation of 6-aminochrysene and the use thereof |
-
1998
- 1998-12-01 US US09/203,650 patent/US6184224B1/en not_active Expired - Fee Related
-
1999
- 1999-11-22 AT AT99965865T patent/ATE278681T1/de not_active IP Right Cessation
- 1999-11-22 EP EP99965865A patent/EP1135379B1/de not_active Expired - Lifetime
- 1999-11-22 WO PCT/US1999/027691 patent/WO2000032583A1/en not_active Ceased
- 1999-11-22 CA CA002352878A patent/CA2352878A1/en not_active Abandoned
- 1999-11-22 DE DE69920953T patent/DE69920953T2/de not_active Expired - Fee Related
- 1999-11-22 JP JP2000585225A patent/JP2002531445A/ja not_active Withdrawn
-
2000
- 2000-08-08 US US09/634,102 patent/US6362200B1/en not_active Expired - Fee Related
-
2002
- 2002-01-14 US US10/047,301 patent/US6479662B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000032583A9 (en) | 2000-11-30 |
| CA2352878A1 (en) | 2000-06-08 |
| US6362200B1 (en) | 2002-03-26 |
| DE69920953T2 (de) | 2006-02-23 |
| US6479662B2 (en) | 2002-11-12 |
| DE69920953D1 (de) | 2004-11-11 |
| US20020103191A1 (en) | 2002-08-01 |
| EP1135379A1 (de) | 2001-09-26 |
| US6184224B1 (en) | 2001-02-06 |
| EP1135379B1 (de) | 2004-10-06 |
| WO2000032583A1 (en) | 2000-06-08 |
| JP2002531445A (ja) | 2002-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69129611D1 (de) | Sulfonamid-Derivate | |
| ATE288465T1 (de) | Lumineszente polymer | |
| ES2036145A1 (es) | Procedimiento de preparacion de derivados de aril (o heteroaril)-pipe-razinil-butil-azoles. | |
| DE69620443D1 (de) | Naphthyl substituierte benzimidazolderivate als antikoagulantien | |
| CA2232728A1 (en) | Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components | |
| MY119820A (en) | Guanidine mimics as factor xa inhibitors | |
| CY1111236T1 (el) | Ανοσοτροποποιητικες ενωσεις που περιεχουν γαμμα-γλουταμυλο και βητα-ασπαρτυλο τμημα και μεθοδοι με αυτες | |
| KR960703864A (ko) | 신규한 축합 인단 유도체 및 그의 약학적으로 허용가능한 염(novel fused indan derivative and pharmaceutically acceptable salt thereof) | |
| EP1201668A4 (de) | Staurosporin-derivate | |
| MXPA02006329A (es) | 8-arilquinolinas sustituidas que son inhibidores de fosfodiesterasa-4. | |
| IT1315267B1 (it) | Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale | |
| EA199900163A1 (ru) | Акрилоил-замещенные производные дистамицина, способы их получения и их применение в качестве противоопухолевых и противовирусных средств | |
| ATE13178T1 (de) | 2-oxoazetidin-derivate, ihre herstellung und verwendung. | |
| ATE219481T1 (de) | 1,7,7-trimethyl-bicyclo(2.2.1)heptane derivative | |
| CA2026599A1 (en) | Process for producing enyne derivatives | |
| TR199700354A2 (xx) | Karbohidrat t�revleri. | |
| ATE278681T1 (de) | Dibenzofluorene derivative als antitumormittel | |
| PT1095040E (pt) | Novos benzoxazoles com actividade inibidora da pde | |
| ES2169220T3 (es) | Derivados de vitamina d3 con sustituyentes en la posicion 2. | |
| EP0683788A1 (de) | 3'-azaridino-anthracyclin-derivate. | |
| AU1018497A (en) | Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient | |
| EP0315434A3 (de) | Pyridoxalhydrazon-Derivate, ihre Herstellung und Verwendung und diese enthaltende Arzneimittel | |
| HUP0001792A2 (hu) | Dibenzo-oxazepin- és -dioxepin-származékok, és felhasználásuk tumorellenes szerként | |
| TR200001080T2 (tr) | 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri | |
| ATE238274T1 (de) | Naphthalin derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |